

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.51390841 |
| 2 | DNA deamination (GO:0045006) | 6.39978436 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.96967319 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.55518647 |
| 5 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.14750002 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.88630421 |
| 7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.88630421 |
| 8 | muscle filament sliding (GO:0030049) | 4.77665566 |
| 9 | actin-myosin filament sliding (GO:0033275) | 4.77665566 |
| 10 | viral transcription (GO:0019083) | 4.65693381 |
| 11 | mast cell activation (GO:0045576) | 4.55335212 |
| 12 | NADH metabolic process (GO:0006734) | 4.54028355 |
| 13 | platelet dense granule organization (GO:0060155) | 4.53910624 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.45260903 |
| 15 | translational termination (GO:0006415) | 4.42896861 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.35068183 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.28329226 |
| 18 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.26709895 |
| 19 | cotranslational protein targeting to membrane (GO:0006613) | 4.19424019 |
| 20 | lymphoid progenitor cell differentiation (GO:0002320) | 4.18404072 |
| 21 | regulation of actin filament-based movement (GO:1903115) | 4.15776311 |
| 22 | regulation of skeletal muscle contraction (GO:0014819) | 4.14861095 |
| 23 | protein targeting to ER (GO:0045047) | 4.14293178 |
| 24 | regulation of relaxation of muscle (GO:1901077) | 4.12489227 |
| 25 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.09597302 |
| 26 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.09381486 |
| 27 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.08786597 |
| 28 | response to interferon-beta (GO:0035456) | 4.08426872 |
| 29 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.07247685 |
| 30 | regulation of cell communication by electrical coupling (GO:0010649) | 4.00769501 |
| 31 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.00720985 |
| 32 | mast cell degranulation (GO:0043303) | 3.99728024 |
| 33 | mast cell activation involved in immune response (GO:0002279) | 3.99728024 |
| 34 | protein localization to endoplasmic reticulum (GO:0070972) | 3.98796491 |
| 35 | ribosomal small subunit biogenesis (GO:0042274) | 3.92624033 |
| 36 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.92138739 |
| 37 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.90772340 |
| 38 | fucose catabolic process (GO:0019317) | 3.87139237 |
| 39 | L-fucose metabolic process (GO:0042354) | 3.87139237 |
| 40 | L-fucose catabolic process (GO:0042355) | 3.87139237 |
| 41 | translational elongation (GO:0006414) | 3.86038950 |
| 42 | actin-mediated cell contraction (GO:0070252) | 3.77919516 |
| 43 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.77222221 |
| 44 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.72646632 |
| 45 | defense response to protozoan (GO:0042832) | 3.60829899 |
| 46 | cellular response to interferon-beta (GO:0035458) | 3.60324769 |
| 47 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.60075988 |
| 48 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.59249042 |
| 49 | xenobiotic catabolic process (GO:0042178) | 3.58456050 |
| 50 | positive regulation of B cell differentiation (GO:0045579) | 3.57725150 |
| 51 | relaxation of cardiac muscle (GO:0055119) | 3.57517901 |
| 52 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.54815814 |
| 53 | cardiac muscle contraction (GO:0060048) | 3.50311862 |
| 54 | cellular potassium ion homeostasis (GO:0030007) | 3.49572684 |
| 55 | negative regulation of phagocytosis (GO:0050765) | 3.47773257 |
| 56 | DNA strand elongation (GO:0022616) | 3.46343295 |
| 57 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.45619190 |
| 58 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.40618336 |
| 59 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.39981667 |
| 60 | relaxation of muscle (GO:0090075) | 3.39152650 |
| 61 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.39058854 |
| 62 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.39058854 |
| 63 | viral life cycle (GO:0019058) | 3.38823945 |
| 64 | telomere maintenance via recombination (GO:0000722) | 3.37562351 |
| 65 | regulation of lipoprotein metabolic process (GO:0050746) | 3.36707904 |
| 66 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.35107046 |
| 67 | response to protozoan (GO:0001562) | 3.33967746 |
| 68 | cellular protein complex disassembly (GO:0043624) | 3.32463048 |
| 69 | regulation of B cell differentiation (GO:0045577) | 3.28560643 |
| 70 | striated muscle contraction (GO:0006941) | 3.27608468 |
| 71 | sarcomere organization (GO:0045214) | 3.26639752 |
| 72 | diacylglycerol metabolic process (GO:0046339) | 3.25673268 |
| 73 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.25524046 |
| 74 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23737914 |
| 75 | respiratory chain complex IV assembly (GO:0008535) | 3.23028504 |
| 76 | maturation of SSU-rRNA (GO:0030490) | 3.20901275 |
| 77 | secretory granule organization (GO:0033363) | 3.19113046 |
| 78 | L-phenylalanine metabolic process (GO:0006558) | 3.18778146 |
| 79 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.18778146 |
| 80 | regulation of striated muscle contraction (GO:0006942) | 3.18374236 |
| 81 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.17446859 |
| 82 | immunoglobulin mediated immune response (GO:0016064) | 3.12856032 |
| 83 | regulation of metalloenzyme activity (GO:0048552) | 3.11759846 |
| 84 | neutrophil mediated immunity (GO:0002446) | 3.11331567 |
| 85 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.09911578 |
| 86 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.09758542 |
| 87 | cellular response to zinc ion (GO:0071294) | 3.09499210 |
| 88 | definitive hemopoiesis (GO:0060216) | 3.03579918 |
| 89 | signal peptide processing (GO:0006465) | 3.03337443 |
| 90 | sodium ion export (GO:0071436) | 3.02319433 |
| 91 | regulation of cholesterol esterification (GO:0010872) | 3.00728927 |
| 92 | polyketide metabolic process (GO:0030638) | 2.98661234 |
| 93 | doxorubicin metabolic process (GO:0044598) | 2.98661234 |
| 94 | daunorubicin metabolic process (GO:0044597) | 2.98661234 |
| 95 | translational initiation (GO:0006413) | 2.98238378 |
| 96 | angiogenesis involved in wound healing (GO:0060055) | 2.96593811 |
| 97 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.96125460 |
| 98 | eosinophil chemotaxis (GO:0048245) | 2.95968500 |
| 99 | DNA replication initiation (GO:0006270) | 2.95939042 |
| 100 | creatine metabolic process (GO:0006600) | 2.93622608 |
| 101 | myofibril assembly (GO:0030239) | 2.93369824 |
| 102 | carnitine shuttle (GO:0006853) | 2.92249543 |
| 103 | response to interferon-alpha (GO:0035455) | 2.91444073 |
| 104 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.89965217 |
| 105 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.89923673 |
| 106 | telomere maintenance via telomere lengthening (GO:0010833) | 2.89000773 |
| 107 | response to misfolded protein (GO:0051788) | 2.88338104 |
| 108 | cardiac myofibril assembly (GO:0055003) | 2.88298131 |
| 109 | response to muscle activity (GO:0014850) | 2.87782829 |
| 110 | regulation of necroptotic process (GO:0060544) | 2.87687928 |
| 111 | protein complex disassembly (GO:0043241) | 2.87003348 |
| 112 | purine-containing compound salvage (GO:0043101) | 2.86929868 |
| 113 | endosome to pigment granule transport (GO:0043485) | 2.86817644 |
| 114 | endosome to melanosome transport (GO:0035646) | 2.86817644 |
| 115 | regulation of necrotic cell death (GO:0010939) | 2.86466985 |
| 116 | myeloid leukocyte mediated immunity (GO:0002444) | 2.83819300 |
| 117 | cell communication by electrical coupling (GO:0010644) | 2.82479578 |
| 118 | necroptotic process (GO:0070266) | 2.81210472 |
| 119 | potassium ion import (GO:0010107) | 2.80984117 |
| 120 | mitotic recombination (GO:0006312) | 2.80664687 |
| 121 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.80474961 |
| 122 | skeletal muscle contraction (GO:0003009) | 2.80295364 |
| 123 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.79357129 |
| 124 | pseudouridine synthesis (GO:0001522) | 2.78344570 |
| 125 | cytochrome complex assembly (GO:0017004) | 2.76785146 |
| 126 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.76273367 |
| 127 | L-phenylalanine catabolic process (GO:0006559) | 2.76273367 |
| 128 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.74971738 |
| 129 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.74971738 |
| 130 | regulation of growth of symbiont in host (GO:0044126) | 2.74971738 |
| 131 | negative regulation of growth of symbiont in host (GO:0044130) | 2.74971738 |
| 132 | positive regulation of respiratory burst (GO:0060267) | 2.74164059 |
| 133 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.72747637 |
| 134 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.72747637 |
| 135 | respiratory burst (GO:0045730) | 2.72315647 |
| 136 | positive regulation of lamellipodium assembly (GO:0010592) | 2.71787285 |
| 137 | leukocyte degranulation (GO:0043299) | 2.71515826 |
| 138 | cellular response to type I interferon (GO:0071357) | 2.70988546 |
| 139 | type I interferon signaling pathway (GO:0060337) | 2.70988546 |
| 140 | protein targeting to membrane (GO:0006612) | 2.70432983 |
| 141 | macromolecular complex disassembly (GO:0032984) | 2.70243132 |
| 142 | glyoxylate metabolic process (GO:0046487) | 2.70085342 |
| 143 | negative regulation of protein localization to cell surface (GO:2000009) | 2.69472791 |
| 144 | response to type I interferon (GO:0034340) | 2.67053169 |
| 145 | regulation of cardiac muscle contraction (GO:0055117) | 2.66310831 |
| 146 | B cell receptor signaling pathway (GO:0050853) | 2.66209467 |
| 147 | mature B cell differentiation involved in immune response (GO:0002313) | 2.65913133 |
| 148 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.65248146 |
| 149 | response to gravity (GO:0009629) | 2.65027442 |
| 150 | T cell homeostasis (GO:0043029) | 2.64926304 |
| 151 | eosinophil migration (GO:0072677) | 2.64660137 |
| 152 | regulation of the force of heart contraction (GO:0002026) | 2.63864521 |
| 153 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.63822362 |
| 154 | cardiac muscle hypertrophy (GO:0003300) | 2.61195130 |
| 155 | translation (GO:0006412) | 2.59960611 |
| 156 | neutrophil activation involved in immune response (GO:0002283) | 2.59885046 |
| 157 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.58494901 |
| 158 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.58494901 |
| 159 | regulation of respiratory burst (GO:0060263) | 2.58046508 |
| 160 | positive regulation of macrophage differentiation (GO:0045651) | 2.56658193 |
| 161 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.56248991 |
| 162 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.55843547 |
| 163 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.55700132 |
| 164 | ubiquinone biosynthetic process (GO:0006744) | 2.55191972 |
| 165 | cellular sodium ion homeostasis (GO:0006883) | 2.54965621 |
| 166 | muscle contraction (GO:0006936) | 2.54469930 |
| 167 | cell communication involved in cardiac conduction (GO:0086065) | 2.53761442 |
| 168 | tricarboxylic acid cycle (GO:0006099) | 2.53620776 |
| 169 | heterotypic cell-cell adhesion (GO:0034113) | 2.52853574 |
| 170 | negative regulation of muscle contraction (GO:0045932) | 2.52632826 |
| 171 | potassium ion homeostasis (GO:0055075) | 2.52180087 |
| 172 | actin filament-based movement (GO:0030048) | 2.51921839 |
| 173 | heart process (GO:0003015) | 2.50988410 |
| 174 | heart contraction (GO:0060047) | 2.50988410 |
| 175 | negative regulation of cation channel activity (GO:2001258) | 2.47494011 |
| 176 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.46274190 |
| 177 | response to mercury ion (GO:0046689) | 2.45643265 |
| 178 | negative regulation of heart contraction (GO:0045822) | 2.45635269 |
| 179 | striated muscle hypertrophy (GO:0014897) | 2.45539012 |
| 180 | detection of calcium ion (GO:0005513) | 2.42508904 |
| 181 | muscle tissue morphogenesis (GO:0060415) | 2.42160546 |
| 182 | muscle system process (GO:0003012) | 2.39655369 |
| 183 | relaxation of smooth muscle (GO:0044557) | 2.37687671 |
| 184 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.36112590 |
| 185 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.35852127 |
| 186 | fatty acid transmembrane transport (GO:1902001) | 2.35561582 |
| 187 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.34900540 |
| 188 | 2-oxoglutarate metabolic process (GO:0006103) | 2.34700605 |
| 189 | coenzyme catabolic process (GO:0009109) | 2.34556598 |
| 190 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.33351636 |
| 191 | quinone biosynthetic process (GO:1901663) | 2.29846246 |
| 192 | response to epinephrine (GO:0071871) | 2.27958815 |
| 193 | actomyosin structure organization (GO:0031032) | 2.27221414 |
| 194 | carnitine transmembrane transport (GO:1902603) | 2.27185995 |
| 195 | protein heterotetramerization (GO:0051290) | 2.26433074 |
| 196 | one-carbon compound transport (GO:0019755) | 2.23732419 |
| 197 | fatty acid elongation (GO:0030497) | 2.23407542 |
| 198 | galactose metabolic process (GO:0006012) | 2.23299436 |
| 199 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.21415498 |
| 200 | positive regulation of cation channel activity (GO:2001259) | 2.21323919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.48338576 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.77671784 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.44419961 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.41171280 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.35821972 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.30666387 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.27344553 |
| 8 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.21453896 |
| 9 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.17997413 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.07568618 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.00869517 |
| 12 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.95645108 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.93519832 |
| 14 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.87266968 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.83507386 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.78638176 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.78405379 |
| 18 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.71465515 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.68225647 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.67863652 |
| 21 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.66215023 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.63017440 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.61771902 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 2.47018264 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.45693521 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.42922393 |
| 27 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41510914 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.41188536 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.34395472 |
| 30 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.32875006 |
| 31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.32073349 |
| 32 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.31858364 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.31052565 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25587109 |
| 35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23233105 |
| 36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20328356 |
| 37 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.20078816 |
| 38 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.16391007 |
| 39 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.15916944 |
| 40 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14207474 |
| 41 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.12877614 |
| 42 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.12119238 |
| 43 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.11817363 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.06551854 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.01710481 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.00800318 |
| 47 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.00667426 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.99163139 |
| 49 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.96845873 |
| 50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.96797937 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.95915814 |
| 52 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.94679107 |
| 53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94092433 |
| 54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93338887 |
| 55 | MYB_26560356_Chip-Seq_TH2_Human | 1.91334821 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.87616746 |
| 57 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.85189705 |
| 58 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.85172676 |
| 59 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.85168723 |
| 60 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.81055392 |
| 61 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.78381611 |
| 62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.78244804 |
| 63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.76838199 |
| 64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74683784 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.72833271 |
| 66 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.72511882 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.70787588 |
| 68 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70111934 |
| 69 | MYC_22102868_ChIP-Seq_BL_Human | 1.69564139 |
| 70 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.68172484 |
| 71 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66174755 |
| 72 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.64059915 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58902534 |
| 74 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.58430149 |
| 75 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.58080081 |
| 76 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.54781667 |
| 77 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.53975580 |
| 78 | MAF_26560356_Chip-Seq_TH1_Human | 1.52501375 |
| 79 | MYB_26560356_Chip-Seq_TH1_Human | 1.52388913 |
| 80 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.51778037 |
| 81 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.51383512 |
| 82 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.51221411 |
| 83 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50189245 |
| 84 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46794407 |
| 85 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.44842592 |
| 86 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.43023805 |
| 87 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.43023805 |
| 88 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.42271857 |
| 89 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41734038 |
| 90 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.38069406 |
| 91 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.37902839 |
| 92 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.36809082 |
| 93 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35286424 |
| 94 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35180594 |
| 95 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.35150206 |
| 96 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.34390315 |
| 97 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.34164151 |
| 98 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.33373739 |
| 99 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32936694 |
| 100 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.29847602 |
| 101 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29828873 |
| 102 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.29493176 |
| 103 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28863501 |
| 104 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.28595210 |
| 105 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.28025133 |
| 106 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27987075 |
| 107 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.27759141 |
| 108 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.27576242 |
| 109 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26723499 |
| 110 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26406019 |
| 111 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25937940 |
| 112 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.25917414 |
| 113 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.25536571 |
| 114 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23999538 |
| 115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23543762 |
| 116 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.23295536 |
| 117 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.22958943 |
| 118 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22791462 |
| 119 | P68_20966046_ChIP-Seq_HELA_Human | 1.21961364 |
| 120 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.20789561 |
| 121 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.20670439 |
| 122 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.20280865 |
| 123 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19097894 |
| 124 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.18816916 |
| 125 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18798728 |
| 126 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.17864286 |
| 127 | SPI1_23127762_ChIP-Seq_K562_Human | 1.17467365 |
| 128 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16768680 |
| 129 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16731172 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14575578 |
| 131 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.10868532 |
| 132 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.09977769 |
| 133 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.09027673 |
| 134 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.08499008 |
| 135 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08492742 |
| 136 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08433043 |
| 137 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.08393667 |
| 138 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08134203 |
| 139 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07919436 |
| 140 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.07767500 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07547369 |
| 142 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07340101 |
| 143 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07102213 |
| 144 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.06366807 |
| 145 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.05394774 |
| 146 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05097093 |
| 147 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04962659 |
| 148 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04643971 |
| 149 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.04166096 |
| 150 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.04166096 |
| 151 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03086168 |
| 152 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.02226075 |
| 153 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.01814028 |
| 154 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.01349459 |
| 155 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01159696 |
| 156 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.00908855 |
| 157 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00382267 |
| 158 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99130157 |
| 159 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97881581 |
| 160 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.97642383 |
| 161 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97394915 |
| 162 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96918884 |
| 163 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.95939480 |
| 164 | MAF_26560356_Chip-Seq_TH2_Human | 0.95930639 |
| 165 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.95592516 |
| 166 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95463177 |
| 167 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95350527 |
| 168 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95315548 |
| 169 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94301460 |
| 170 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93948937 |
| 171 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.92443515 |
| 172 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92411293 |
| 173 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92195486 |
| 174 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91407157 |
| 175 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.90849322 |
| 176 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.90841077 |
| 177 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.90802533 |
| 178 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89922900 |
| 179 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.89306601 |
| 180 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.89213804 |
| 181 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.88940154 |
| 182 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.88580518 |
| 183 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.88296089 |
| 184 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.88214658 |
| 185 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.88208870 |
| 186 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87952310 |
| 187 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87020250 |
| 188 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86639521 |
| 189 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.85592798 |
| 190 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.84683784 |
| 191 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.83559424 |
| 192 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.82344064 |
| 193 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82271461 |
| 194 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81173351 |
| 195 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79896972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.25165867 |
| 2 | MP0002396_abnormal_hematopoietic_system | 4.18869178 |
| 3 | MP0000751_myopathy | 4.17982859 |
| 4 | MP0000749_muscle_degeneration | 3.31583438 |
| 5 | MP0009785_altered_susceptibility_to | 3.22447395 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 3.15296617 |
| 7 | MP0004036_abnormal_muscle_relaxation | 3.14242952 |
| 8 | MP0005671_abnormal_response_to | 3.12539087 |
| 9 | MP0000685_abnormal_immune_system | 3.10896309 |
| 10 | MP0004084_abnormal_cardiac_muscle | 3.07415779 |
| 11 | MP0005174_abnormal_tail_pigmentation | 3.05295125 |
| 12 | MP0003646_muscle_fatigue | 2.83421239 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.76131972 |
| 14 | MP0002166_altered_tumor_susceptibility | 2.71864261 |
| 15 | MP0005025_abnormal_response_to | 2.63588582 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.61905101 |
| 17 | MP0005670_abnormal_white_adipose | 2.53978260 |
| 18 | MP0005075_abnormal_melanosome_morpholog | 2.40927516 |
| 19 | MP0002419_abnormal_innate_immunity | 2.38204822 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.37000354 |
| 21 | MP0009379_abnormal_foot_pigmentation | 2.35433965 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 2.34729522 |
| 23 | MP0005000_abnormal_immune_tolerance | 2.34469260 |
| 24 | MP0001819_abnormal_immune_cell | 2.33236880 |
| 25 | MP0003724_increased_susceptibility_to | 2.32665450 |
| 26 | MP0005330_cardiomyopathy | 2.31089399 |
| 27 | MP0001853_heart_inflammation | 2.29940362 |
| 28 | MP0002006_tumorigenesis | 2.25654498 |
| 29 | * MP0002723_abnormal_immune_serum | 2.23670614 |
| 30 | MP0002398_abnormal_bone_marrow | 2.23094695 |
| 31 | MP0003329_amyloid_beta_deposits | 2.22046929 |
| 32 | MP0001800_abnormal_humoral_immune | 2.20621643 |
| 33 | MP0004215_abnormal_myocardial_fiber | 2.17556256 |
| 34 | MP0002452_abnormal_antigen_presenting | 2.17472849 |
| 35 | MP0005464_abnormal_platelet_physiology | 2.17063536 |
| 36 | MP0003436_decreased_susceptibility_to | 2.08193528 |
| 37 | MP0009840_abnormal_foam_cell | 2.07411578 |
| 38 | MP0001545_abnormal_hematopoietic_system | 2.05639945 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 2.05639945 |
| 40 | MP0005165_increased_susceptibility_to | 2.03263845 |
| 41 | MP0000716_abnormal_immune_system | 2.02406238 |
| 42 | MP0004270_analgesia | 2.01591580 |
| 43 | MP0000015_abnormal_ear_pigmentation | 2.00498614 |
| 44 | MP0002972_abnormal_cardiac_muscle | 1.98402698 |
| 45 | MP0002095_abnormal_skin_pigmentation | 1.94077012 |
| 46 | MP0005620_abnormal_muscle_contractility | 1.93966671 |
| 47 | MP0004087_abnormal_muscle_fiber | 1.93574234 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.90537963 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.88725558 |
| 50 | MP0010386_abnormal_urinary_bladder | 1.86608658 |
| 51 | MP0001873_stomach_inflammation | 1.86117505 |
| 52 | MP0000747_muscle_weakness | 1.86051071 |
| 53 | MP0001790_abnormal_immune_system | 1.85837915 |
| 54 | MP0005387_immune_system_phenotype | 1.85837915 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.83454296 |
| 56 | MP0003866_abnormal_defecation | 1.83246752 |
| 57 | MP0000750_abnormal_muscle_regeneration | 1.81762009 |
| 58 | MP0002722_abnormal_immune_system | 1.78782030 |
| 59 | MP0008260_abnormal_autophagy | 1.78142547 |
| 60 | MP0000490_abnormal_crypts_of | 1.77483953 |
| 61 | MP0002429_abnormal_blood_cell | 1.76033322 |
| 62 | MP0002332_abnormal_exercise_endurance | 1.74647421 |
| 63 | MP0002106_abnormal_muscle_physiology | 1.74244761 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.66625807 |
| 65 | MP0000465_gastrointestinal_hemorrhage | 1.66096651 |
| 66 | MP0001986_abnormal_taste_sensitivity | 1.65102393 |
| 67 | MP0000920_abnormal_myelination | 1.64636805 |
| 68 | MP0009780_abnormal_chondrocyte_physiolo | 1.61908256 |
| 69 | MP0000759_abnormal_skeletal_muscle | 1.61793086 |
| 70 | MP0009333_abnormal_splenocyte_physiolog | 1.61673254 |
| 71 | MP0002405_respiratory_system_inflammati | 1.61636983 |
| 72 | MP0003137_abnormal_impulse_conducting | 1.60590173 |
| 73 | MP0003690_abnormal_glial_cell | 1.57542713 |
| 74 | MP0005451_abnormal_body_composition | 1.56243943 |
| 75 | MP0004484_altered_response_of | 1.50229239 |
| 76 | MP0005369_muscle_phenotype | 1.49458039 |
| 77 | MP0005409_darkened_coat_color | 1.49008206 |
| 78 | MP0005166_decreased_susceptibility_to | 1.48788759 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.44452631 |
| 80 | MP0006138_congestive_heart_failure | 1.44364835 |
| 81 | MP0002269_muscular_atrophy | 1.42908523 |
| 82 | MP0000703_abnormal_thymus_morphology | 1.42269768 |
| 83 | MP0004233_abnormal_muscle_weight | 1.42126350 |
| 84 | MP0008775_abnormal_heart_ventricle | 1.41352146 |
| 85 | MP0003011_delayed_dark_adaptation | 1.38719647 |
| 86 | MP0008875_abnormal_xenobiotic_pharmacok | 1.37207373 |
| 87 | MP0000604_amyloidosis | 1.35389964 |
| 88 | MP0002734_abnormal_mechanical_nocicepti | 1.32903145 |
| 89 | MP0010094_abnormal_chromosome_stability | 1.28438091 |
| 90 | MP0004147_increased_porphyrin_level | 1.26534882 |
| 91 | MP0005360_urolithiasis | 1.25650220 |
| 92 | MP0006292_abnormal_olfactory_placode | 1.21974196 |
| 93 | MP0008007_abnormal_cellular_replicative | 1.21669321 |
| 94 | MP0001188_hyperpigmentation | 1.21418064 |
| 95 | MP0002064_seizures | 1.20572753 |
| 96 | * MP0008469_abnormal_protein_level | 1.20292166 |
| 97 | MP0003045_fibrosis | 1.19606761 |
| 98 | MP0003693_abnormal_embryo_hatching | 1.18585066 |
| 99 | MP0005365_abnormal_bile_salt | 1.17662127 |
| 100 | MP0003075_altered_response_to | 1.16962957 |
| 101 | MP0001486_abnormal_startle_reflex | 1.15240813 |
| 102 | MP0005385_cardiovascular_system_phenoty | 1.15111837 |
| 103 | MP0001544_abnormal_cardiovascular_syste | 1.15111837 |
| 104 | MP0000858_altered_metastatic_potential | 1.12713211 |
| 105 | MP0008569_lethality_at_weaning | 1.12074245 |
| 106 | MP0001970_abnormal_pain_threshold | 1.11157240 |
| 107 | MP0008058_abnormal_DNA_repair | 1.10433612 |
| 108 | MP0003183_abnormal_peptide_metabolism | 1.10184544 |
| 109 | MP0006036_abnormal_mitochondrial_physio | 1.09887644 |
| 110 | MP0009745_abnormal_behavioral_response | 1.09501960 |
| 111 | MP0004130_abnormal_muscle_cell | 1.09441610 |
| 112 | MP0002736_abnormal_nociception_after | 1.08717530 |
| 113 | MP0000343_altered_response_to | 1.08131459 |
| 114 | MP0003635_abnormal_synaptic_transmissio | 1.05318685 |
| 115 | MP0008057_abnormal_DNA_replication | 1.04749066 |
| 116 | MP0001984_abnormal_olfaction | 1.04184708 |
| 117 | MP0003880_abnormal_central_pattern | 1.02416380 |
| 118 | MP0001502_abnormal_circadian_rhythm | 1.02389845 |
| 119 | MP0010630_abnormal_cardiac_muscle | 1.01780727 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 1.01196346 |
| 121 | MP0000372_irregular_coat_pigmentation | 1.00904220 |
| 122 | MP0002019_abnormal_tumor_incidence | 1.00395318 |
| 123 | MP0001905_abnormal_dopamine_level | 0.99639713 |
| 124 | MP0002735_abnormal_chemical_nociception | 0.98492831 |
| 125 | MP0002272_abnormal_nervous_system | 0.96878558 |
| 126 | MP0005379_endocrine/exocrine_gland_phen | 0.95156347 |
| 127 | MP0001958_emphysema | 0.94700740 |
| 128 | MP0001663_abnormal_digestive_system | 0.94045368 |
| 129 | MP0002877_abnormal_melanocyte_morpholog | 0.93040370 |
| 130 | MP0000462_abnormal_digestive_system | 0.89548268 |
| 131 | MP0000538_abnormal_urinary_bladder | 0.88664541 |
| 132 | MP0002572_abnormal_emotion/affect_behav | 0.88316185 |
| 133 | MP0000681_abnormal_thyroid_gland | 0.88074134 |
| 134 | MP0002132_abnormal_respiratory_system | 0.87825398 |
| 135 | MP0004085_abnormal_heartbeat | 0.87562847 |
| 136 | MP0003634_abnormal_glial_cell | 0.86856911 |
| 137 | MP0002733_abnormal_thermal_nociception | 0.86397331 |
| 138 | MP0001968_abnormal_touch/_nociception | 0.84854470 |
| 139 | MP0002063_abnormal_learning/memory/cond | 0.84695944 |
| 140 | MP0003186_abnormal_redox_activity | 0.84380737 |
| 141 | MP0003279_aneurysm | 0.83286697 |
| 142 | MP0003879_abnormal_hair_cell | 0.82849625 |
| 143 | MP0005310_abnormal_salivary_gland | 0.81356120 |
| 144 | MP0002909_abnormal_adrenal_gland | 0.80696131 |
| 145 | MP0003656_abnormal_erythrocyte_physiolo | 0.78979381 |
| 146 | MP0001533_abnormal_skeleton_physiology | 0.78787057 |
| 147 | MP0001661_extended_life_span | 0.78431230 |
| 148 | MP0003303_peritoneal_inflammation | 0.78040865 |
| 149 | MP0000013_abnormal_adipose_tissue | 0.75871603 |
| 150 | MP0001529_abnormal_vocalization | 0.75668359 |
| 151 | MP0009764_decreased_sensitivity_to | 0.75194813 |
| 152 | MP0002108_abnormal_muscle_morphology | 0.74680625 |
| 153 | MP0004924_abnormal_behavior | 0.74521509 |
| 154 | MP0005386_behavior/neurological_phenoty | 0.74521509 |
| 155 | MP0000249_abnormal_blood_vessel | 0.74397088 |
| 156 | MP0002075_abnormal_coat/hair_pigmentati | 0.73932653 |
| 157 | MP0002933_joint_inflammation | 0.73430341 |
| 158 | MP0005332_abnormal_amino_acid | 0.72601945 |
| 159 | MP0002822_catalepsy | 0.70238756 |
| 160 | MP0005058_abnormal_lysosome_morphology | 0.70027476 |
| 161 | MP0009046_muscle_twitch | 0.67727295 |
| 162 | MP0002876_abnormal_thyroid_physiology | 0.67524514 |
| 163 | MP0003638_abnormal_response/metabolism_ | 0.67166868 |
| 164 | MP0005666_abnormal_adipose_tissue | 0.66394181 |
| 165 | MP0004947_skin_inflammation | 0.65743388 |
| 166 | MP0001764_abnormal_homeostasis | 0.65677102 |
| 167 | MP0004957_abnormal_blastocyst_morpholog | 0.65644652 |
| 168 | MP0004510_myositis | 0.63515679 |
| 169 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.63419854 |
| 170 | MP0000371_diluted_coat_color | 0.63104530 |
| 171 | MP0004859_abnormal_synaptic_plasticity | 0.61377989 |
| 172 | MP0000313_abnormal_cell_death | 0.60189955 |
| 173 | MP0003077_abnormal_cell_cycle | 0.57710548 |
| 174 | MP0005423_abnormal_somatic_nervous | 0.56983609 |
| 175 | MP0006082_CNS_inflammation | 0.55787395 |
| 176 | MP0002638_abnormal_pupillary_reflex | 0.55652878 |
| 177 | MP0004381_abnormal_hair_follicle | 0.55557035 |
| 178 | MP0009763_increased_sensitivity_to | 0.55519511 |
| 179 | MP0001851_eye_inflammation | 0.55165848 |
| 180 | MP0006054_spinal_hemorrhage | 0.54942652 |
| 181 | MP0003191_abnormal_cellular_cholesterol | 0.54603383 |
| 182 | MP0008874_decreased_physiological_sensi | 0.54494547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.79962655 |
| 2 | Thrombocytosis (HP:0001894) | 5.44135915 |
| 3 | Exercise-induced myalgia (HP:0003738) | 4.88043514 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 4.73123784 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.67976146 |
| 6 | Nemaline bodies (HP:0003798) | 4.53664780 |
| 7 | Hyporeflexia of lower limbs (HP:0002600) | 4.52305488 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.42559301 |
| 9 | Aplastic anemia (HP:0001915) | 4.42483680 |
| 10 | Abnormal number of erythroid precursors (HP:0012131) | 4.36930130 |
| 11 | Myositis (HP:0100614) | 4.36204877 |
| 12 | IgM deficiency (HP:0002850) | 4.32090005 |
| 13 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.22792760 |
| 14 | Sudden death (HP:0001699) | 4.22017390 |
| 15 | Chronic otitis media (HP:0000389) | 4.18950453 |
| 16 | Type 1 muscle fiber predominance (HP:0003803) | 4.12416332 |
| 17 | Muscle fiber splitting (HP:0003555) | 4.06764197 |
| 18 | Distal lower limb muscle weakness (HP:0009053) | 4.03322406 |
| 19 | Reduced antithrombin III activity (HP:0001976) | 4.02374777 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.97583643 |
| 21 | Type I transferrin isoform profile (HP:0003642) | 3.78277602 |
| 22 | Abnormality of the calf musculature (HP:0001430) | 3.75127870 |
| 23 | Rhabdomyolysis (HP:0003201) | 3.71844451 |
| 24 | Reticulocytopenia (HP:0001896) | 3.64204606 |
| 25 | Exercise-induced muscle cramps (HP:0003710) | 3.62309144 |
| 26 | Atrioventricular block (HP:0001678) | 3.60124930 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 3.56099380 |
| 28 | Ventricular tachycardia (HP:0004756) | 3.55315776 |
| 29 | Increased variability in muscle fiber diameter (HP:0003557) | 3.54597918 |
| 30 | Abnormal atrioventricular conduction (HP:0005150) | 3.52720735 |
| 31 | Heart block (HP:0012722) | 3.49667701 |
| 32 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.48494465 |
| 33 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.45386843 |
| 34 | Bundle branch block (HP:0011710) | 3.44814193 |
| 35 | EMG: myopathic abnormalities (HP:0003458) | 3.39926325 |
| 36 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.36637828 |
| 37 | Periodontitis (HP:0000704) | 3.27942712 |
| 38 | Calf muscle hypertrophy (HP:0008981) | 3.25919720 |
| 39 | B lymphocytopenia (HP:0010976) | 3.23632321 |
| 40 | Abnormality of B cell number (HP:0010975) | 3.23632321 |
| 41 | Recurrent bronchitis (HP:0002837) | 3.21880043 |
| 42 | Panhypogammaglobulinemia (HP:0003139) | 3.19386919 |
| 43 | Abnormality of T cell physiology (HP:0011840) | 3.09476830 |
| 44 | Petechiae (HP:0000967) | 3.04701019 |
| 45 | Abnormal protein glycosylation (HP:0012346) | 3.00966687 |
| 46 | Abnormal glycosylation (HP:0012345) | 3.00966687 |
| 47 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.00966687 |
| 48 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.00966687 |
| 49 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.00607143 |
| 50 | Ventricular arrhythmia (HP:0004308) | 2.97040667 |
| 51 | Neck muscle weakness (HP:0000467) | 2.93959886 |
| 52 | Abnormality of binocular vision (HP:0011514) | 2.93723270 |
| 53 | Diplopia (HP:0000651) | 2.93723270 |
| 54 | Hypoplasia of the thymus (HP:0000778) | 2.93026849 |
| 55 | Asymmetric septal hypertrophy (HP:0001670) | 2.92905303 |
| 56 | Myoglobinuria (HP:0002913) | 2.91078754 |
| 57 | Bulbar palsy (HP:0001283) | 2.84526870 |
| 58 | IgG deficiency (HP:0004315) | 2.79687626 |
| 59 | Acute lymphatic leukemia (HP:0006721) | 2.78665934 |
| 60 | Hepatocellular necrosis (HP:0001404) | 2.77890832 |
| 61 | Meningitis (HP:0001287) | 2.76766523 |
| 62 | Myopathic facies (HP:0002058) | 2.75466554 |
| 63 | Hypoproteinemia (HP:0003075) | 2.70621619 |
| 64 | Recurrent skin infections (HP:0001581) | 2.67200673 |
| 65 | Albinism (HP:0001022) | 2.66167106 |
| 66 | Abnormality of T cells (HP:0002843) | 2.65661821 |
| 67 | Type 2 muscle fiber atrophy (HP:0003554) | 2.63724391 |
| 68 | Areflexia of lower limbs (HP:0002522) | 2.63646483 |
| 69 | Mediastinal lymphadenopathy (HP:0100721) | 2.63458401 |
| 70 | Poikiloderma (HP:0001029) | 2.62489931 |
| 71 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.61522699 |
| 72 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.61522699 |
| 73 | Thyroiditis (HP:0100646) | 2.60731112 |
| 74 | Dilated cardiomyopathy (HP:0001644) | 2.57954032 |
| 75 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.51697076 |
| 76 | Muscle fiber atrophy (HP:0100295) | 2.51657727 |
| 77 | Recurrent fungal infections (HP:0002841) | 2.51572197 |
| 78 | Abnormality of the prostate (HP:0008775) | 2.51300571 |
| 79 | Pallor (HP:0000980) | 2.49391593 |
| 80 | Abnormality of macrophages (HP:0004311) | 2.49182195 |
| 81 | EMG: neuropathic changes (HP:0003445) | 2.48448143 |
| 82 | Severe combined immunodeficiency (HP:0004430) | 2.47425959 |
| 83 | Lipoatrophy (HP:0100578) | 2.47372349 |
| 84 | Abnormality of the columella (HP:0009929) | 2.46298299 |
| 85 | Eczematoid dermatitis (HP:0000976) | 2.46111179 |
| 86 | Hepatic necrosis (HP:0002605) | 2.45276710 |
| 87 | Exertional dyspnea (HP:0002875) | 2.45127994 |
| 88 | Obstructive lung disease (HP:0006536) | 2.44951852 |
| 89 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44951852 |
| 90 | Recurrent viral infections (HP:0004429) | 2.44948901 |
| 91 | Increased connective tissue (HP:0009025) | 2.43260312 |
| 92 | Increased intramyocellular lipid droplets (HP:0012240) | 2.42876745 |
| 93 | Recurrent cutaneous fungal infections (HP:0011370) | 2.42620552 |
| 94 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.42620552 |
| 95 | Increased hepatocellular lipid droplets (HP:0006565) | 2.42361373 |
| 96 | Abnormality of the foot musculature (HP:0001436) | 2.41564858 |
| 97 | Prolonged bleeding time (HP:0003010) | 2.39742264 |
| 98 | Abnormality of the Achilles tendon (HP:0005109) | 2.39184779 |
| 99 | Foot dorsiflexor weakness (HP:0009027) | 2.38359626 |
| 100 | Pancytopenia (HP:0001876) | 2.35779140 |
| 101 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.33652165 |
| 102 | Distal arthrogryposis (HP:0005684) | 2.31657053 |
| 103 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.31579044 |
| 104 | Tetraplegia (HP:0002445) | 2.31526107 |
| 105 | Hypergammaglobulinemia (HP:0010702) | 2.31235613 |
| 106 | Myokymia (HP:0002411) | 2.30584949 |
| 107 | Rimmed vacuoles (HP:0003805) | 2.30441555 |
| 108 | Axonal loss (HP:0003447) | 2.30069339 |
| 109 | Achilles tendon contracture (HP:0001771) | 2.29630645 |
| 110 | Syncope (HP:0001279) | 2.28205674 |
| 111 | Macrocytic anemia (HP:0001972) | 2.27741861 |
| 112 | Nasal polyposis (HP:0100582) | 2.25907908 |
| 113 | Mitochondrial inheritance (HP:0001427) | 2.24690354 |
| 114 | Epistaxis (HP:0000421) | 2.24258146 |
| 115 | Atrial fibrillation (HP:0005110) | 2.22867720 |
| 116 | Supraventricular tachycardia (HP:0004755) | 2.22277285 |
| 117 | Nasal speech (HP:0001611) | 2.21501035 |
| 118 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.21357495 |
| 119 | Gingivitis (HP:0000230) | 2.21344148 |
| 120 | Systemic lupus erythematosus (HP:0002725) | 2.21097504 |
| 121 | Lymphoma (HP:0002665) | 2.20785176 |
| 122 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.20528173 |
| 123 | Primary atrial arrhythmia (HP:0001692) | 2.20067415 |
| 124 | Round ear (HP:0100830) | 2.19789460 |
| 125 | Renal Fanconi syndrome (HP:0001994) | 2.17920671 |
| 126 | Severe visual impairment (HP:0001141) | 2.17388281 |
| 127 | Acute necrotizing encephalopathy (HP:0006965) | 2.16868012 |
| 128 | Neurofibrillary tangles (HP:0002185) | 2.15925407 |
| 129 | Supraventricular arrhythmia (HP:0005115) | 2.15411376 |
| 130 | Lymphopenia (HP:0001888) | 2.15363361 |
| 131 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.14645861 |
| 132 | Vacuolated lymphocytes (HP:0001922) | 2.13953506 |
| 133 | 3-Methylglutaconic aciduria (HP:0003535) | 2.13091221 |
| 134 | Orchitis (HP:0100796) | 2.12874425 |
| 135 | Increased muscle lipid content (HP:0009058) | 2.12372832 |
| 136 | Chronic sinusitis (HP:0011109) | 2.11166300 |
| 137 | Abnormality of eosinophils (HP:0001879) | 2.11064066 |
| 138 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.10713201 |
| 139 | Subaortic stenosis (HP:0001682) | 2.10713201 |
| 140 | Amyloidosis (HP:0011034) | 2.10675953 |
| 141 | Agammaglobulinemia (HP:0004432) | 2.10432594 |
| 142 | Erythema (HP:0010783) | 2.10346390 |
| 143 | Papilledema (HP:0001085) | 2.09530112 |
| 144 | Weak cry (HP:0001612) | 2.08970763 |
| 145 | Abnormality of the nasal mucosa (HP:0000433) | 2.08527569 |
| 146 | Lipid accumulation in hepatocytes (HP:0006561) | 2.07895193 |
| 147 | Pulmonary fibrosis (HP:0002206) | 2.06430386 |
| 148 | Progressive macrocephaly (HP:0004481) | 2.05330429 |
| 149 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05273515 |
| 150 | Hypothermia (HP:0002045) | 2.05081749 |
| 151 | Muscle stiffness (HP:0003552) | 2.04712439 |
| 152 | Granulocytopenia (HP:0001913) | 2.03674593 |
| 153 | Abnormality of DNA repair (HP:0003254) | 2.02750384 |
| 154 | Myotonia (HP:0002486) | 2.02531270 |
| 155 | Neutropenia (HP:0001875) | 2.02526583 |
| 156 | Basal ganglia calcification (HP:0002135) | 2.00725230 |
| 157 | Gowers sign (HP:0003391) | 2.00110331 |
| 158 | 11 pairs of ribs (HP:0000878) | 2.00100857 |
| 159 | Hemiplegia (HP:0002301) | 1.99250526 |
| 160 | Abnormal platelet function (HP:0011869) | 1.97843770 |
| 161 | Impaired platelet aggregation (HP:0003540) | 1.97843770 |
| 162 | Chest pain (HP:0100749) | 1.97025147 |
| 163 | Increased CSF lactate (HP:0002490) | 1.96384948 |
| 164 | Vasculitis (HP:0002633) | 1.96370000 |
| 165 | Limb-girdle muscle atrophy (HP:0003797) | 1.94977143 |
| 166 | Large eyes (HP:0001090) | 1.94458491 |
| 167 | Acute myeloid leukemia (HP:0004808) | 1.93599321 |
| 168 | Abnormality of alanine metabolism (HP:0010916) | 1.93439471 |
| 169 | Hyperalaninemia (HP:0003348) | 1.93439471 |
| 170 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.93439471 |
| 171 | Distal lower limb amyotrophy (HP:0008944) | 1.93263259 |
| 172 | Interstitial pulmonary disease (HP:0006530) | 1.92918490 |
| 173 | Acute encephalopathy (HP:0006846) | 1.90530586 |
| 174 | Right ventricular cardiomyopathy (HP:0011663) | 1.88424213 |
| 175 | Abnormal pupillary function (HP:0007686) | 1.88307592 |
| 176 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.87857824 |
| 177 | Nonprogressive disorder (HP:0003680) | 1.87534582 |
| 178 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.85645544 |
| 179 | Ventricular fibrillation (HP:0001663) | 1.84573554 |
| 180 | Complement deficiency (HP:0004431) | 1.82532764 |
| 181 | Scapular winging (HP:0003691) | 1.82324796 |
| 182 | Ulnar deviation of the wrist (HP:0003049) | 1.81728492 |
| 183 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.79484421 |
| 184 | Ankle clonus (HP:0011448) | 1.79432291 |
| 185 | Joint hemorrhage (HP:0005261) | 1.78167933 |
| 186 | Abnormality of the tricuspid valve (HP:0001702) | 1.78061897 |
| 187 | Chronic bronchitis (HP:0004469) | 1.77692407 |
| 188 | Difficulty climbing stairs (HP:0003551) | 1.74496443 |
| 189 | Sparse scalp hair (HP:0002209) | 1.73082170 |
| 190 | Deep venous thrombosis (HP:0002625) | 1.72595004 |
| 191 | Bradycardia (HP:0001662) | 1.72116135 |
| 192 | Fetal akinesia sequence (HP:0001989) | 1.71617624 |
| 193 | Abnormality of the intervertebral disk (HP:0005108) | 1.70009218 |
| 194 | Ragged-red muscle fibers (HP:0003200) | 1.69519023 |
| 195 | Frequent falls (HP:0002359) | 1.68902091 |
| 196 | Spinal rigidity (HP:0003306) | 1.68608781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 3.93955117 |
| 2 | KIT | 3.57230788 |
| 3 | STK16 | 3.44842186 |
| 4 | FLT3 | 3.41218218 |
| 5 | OBSCN | 3.35272341 |
| 6 | TTN | 3.27983790 |
| 7 | MAP3K12 | 3.26446809 |
| 8 | PHKG2 | 3.25866135 |
| 9 | PHKG1 | 3.25866135 |
| 10 | PBK | 3.13071536 |
| 11 | TEC | 2.84629428 |
| 12 | MAP4K1 | 2.80454645 |
| 13 | PRKCH | 2.77755100 |
| 14 | CDK19 | 2.51665158 |
| 15 | LMTK2 | 2.40875329 |
| 16 | RIPK4 | 2.39880577 |
| 17 | CAMKK2 | 2.34279733 |
| 18 | LIMK1 | 2.20189620 |
| 19 | NME2 | 2.18648198 |
| 20 | IRAK4 | 2.18089637 |
| 21 | MUSK | 2.09708283 |
| 22 | PIM2 | 2.08203619 |
| 23 | TESK1 | 2.02639851 |
| 24 | BTK | 1.99776440 |
| 25 | NTRK3 | 1.97918474 |
| 26 | ICK | 1.96969125 |
| 27 | CSF1R | 1.95595684 |
| 28 | EIF2AK3 | 1.89355638 |
| 29 | CAMK2G | 1.81834282 |
| 30 | FES | 1.80192667 |
| 31 | WEE1 | 1.78988326 |
| 32 | SCYL2 | 1.77166944 |
| 33 | ZAP70 | 1.74858130 |
| 34 | SYK | 1.69568520 |
| 35 | BLK | 1.69064635 |
| 36 | TXK | 1.69016163 |
| 37 | TBK1 | 1.59596677 |
| 38 | PRKD3 | 1.57652073 |
| 39 | PDK2 | 1.55908220 |
| 40 | EPHA2 | 1.54722327 |
| 41 | VRK1 | 1.51296996 |
| 42 | DAPK1 | 1.43530546 |
| 43 | KDR | 1.40661407 |
| 44 | MST1R | 1.38753909 |
| 45 | MAP2K3 | 1.36493848 |
| 46 | ADRBK2 | 1.34463590 |
| 47 | IKBKE | 1.31294939 |
| 48 | TYRO3 | 1.30959301 |
| 49 | CAMK2D | 1.28776182 |
| 50 | EEF2K | 1.28109826 |
| 51 | CAMK2B | 1.24954279 |
| 52 | EPHA3 | 1.22713036 |
| 53 | MYLK | 1.22370022 |
| 54 | EPHB1 | 1.21840548 |
| 55 | EPHA4 | 1.20525946 |
| 56 | LYN | 1.11617685 |
| 57 | ACVR1B | 1.11384898 |
| 58 | DAPK3 | 1.10545919 |
| 59 | JAK3 | 1.10217430 |
| 60 | DMPK | 1.05980720 |
| 61 | NTRK1 | 1.03634562 |
| 62 | TYK2 | 1.03620658 |
| 63 | MARK1 | 1.03547952 |
| 64 | EIF2AK1 | 1.03011433 |
| 65 | BRSK2 | 1.02737795 |
| 66 | TAOK3 | 1.02439138 |
| 67 | DAPK2 | 1.01897713 |
| 68 | TESK2 | 0.99662448 |
| 69 | MAP2K7 | 0.98444544 |
| 70 | CCNB1 | 0.98169699 |
| 71 | PINK1 | 0.97294272 |
| 72 | CAMK2A | 0.96356369 |
| 73 | RAF1 | 0.96183167 |
| 74 | NLK | 0.95845284 |
| 75 | CAMK1 | 0.95177320 |
| 76 | LCK | 0.94313838 |
| 77 | MATK | 0.93342189 |
| 78 | TNK2 | 0.90762176 |
| 79 | ROCK1 | 0.89897555 |
| 80 | PKN1 | 0.86474306 |
| 81 | MKNK2 | 0.86176998 |
| 82 | CDK8 | 0.85875403 |
| 83 | TGFBR1 | 0.85203084 |
| 84 | DYRK3 | 0.85135742 |
| 85 | RIPK1 | 0.84976722 |
| 86 | MAPKAPK5 | 0.84692769 |
| 87 | MAPKAPK3 | 0.83892907 |
| 88 | TRIB3 | 0.82337322 |
| 89 | VRK2 | 0.81153672 |
| 90 | FER | 0.80592641 |
| 91 | CAMKK1 | 0.78399171 |
| 92 | GRK5 | 0.77195312 |
| 93 | PRKD1 | 0.76770674 |
| 94 | GRK6 | 0.76487942 |
| 95 | RPS6KB2 | 0.76166023 |
| 96 | MKNK1 | 0.74851803 |
| 97 | PAK6 | 0.74139180 |
| 98 | PDPK1 | 0.73995688 |
| 99 | IRAK3 | 0.72391490 |
| 100 | BCKDK | 0.71608309 |
| 101 | MAP3K3 | 0.70595556 |
| 102 | LRRK2 | 0.69174055 |
| 103 | ROCK2 | 0.66213168 |
| 104 | RET | 0.65415575 |
| 105 | CDC7 | 0.63282690 |
| 106 | PDK1 | 0.63175809 |
| 107 | IKBKB | 0.62747725 |
| 108 | MAP3K13 | 0.62343445 |
| 109 | MAP3K6 | 0.61864604 |
| 110 | SIK3 | 0.61450237 |
| 111 | MAP2K1 | 0.60779799 |
| 112 | HCK | 0.59494362 |
| 113 | MAPK4 | 0.59178377 |
| 114 | RPS6KA2 | 0.58914777 |
| 115 | ERN1 | 0.58608325 |
| 116 | PIK3CG | 0.58127343 |
| 117 | ITK | 0.56706902 |
| 118 | ARAF | 0.55624059 |
| 119 | MAP3K1 | 0.55045284 |
| 120 | CLK1 | 0.54595217 |
| 121 | MET | 0.53323187 |
| 122 | MAP3K2 | 0.52303681 |
| 123 | PAK3 | 0.50893475 |
| 124 | MAP3K11 | 0.50158297 |
| 125 | ILK | 0.48440503 |
| 126 | YES1 | 0.48387279 |
| 127 | PIK3CA | 0.47989926 |
| 128 | KSR2 | 0.47913307 |
| 129 | ATR | 0.45554903 |
| 130 | CDK7 | 0.45115602 |
| 131 | MINK1 | 0.44773546 |
| 132 | TLK1 | 0.44319394 |
| 133 | PRKACA | 0.43535682 |
| 134 | PRPF4B | 0.43516148 |
| 135 | ADRBK1 | 0.43479123 |
| 136 | PIM1 | 0.43257988 |
| 137 | BUB1 | 0.43190821 |
| 138 | AKT2 | 0.42254242 |
| 139 | PRKG2 | 0.42050914 |
| 140 | STK38 | 0.41663253 |
| 141 | MAPK15 | 0.41599727 |
| 142 | PTK2B | 0.41596257 |
| 143 | BRSK1 | 0.40481698 |
| 144 | EIF2AK2 | 0.38878566 |
| 145 | PRKCQ | 0.38581752 |
| 146 | JAK1 | 0.38525653 |
| 147 | ERBB4 | 0.38376165 |
| 148 | CSK | 0.37789099 |
| 149 | GSK3A | 0.37699430 |
| 150 | MAP2K6 | 0.37463527 |
| 151 | SRC | 0.36167008 |
| 152 | PRKACG | 0.35049952 |
| 153 | GRK7 | 0.33898750 |
| 154 | PRKCA | 0.33763836 |
| 155 | BMPR1B | 0.32489040 |
| 156 | PRKCD | 0.32022583 |
| 157 | NME1 | 0.30221929 |
| 158 | PASK | 0.28392487 |
| 159 | TGFBR2 | 0.27640467 |
| 160 | MAP3K14 | 0.27166672 |
| 161 | RPS6KA6 | 0.26204242 |
| 162 | ABL2 | 0.25055454 |
| 163 | TAOK2 | 0.24228368 |
| 164 | MAPK11 | 0.24048510 |
| 165 | PAK4 | 0.23902730 |
| 166 | MAPK12 | 0.23494722 |
| 167 | MAP3K7 | 0.23305975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.52594141 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.44475604 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.10380795 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.10044947 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.02614856 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.86667267 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.60283893 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.52023073 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.42783077 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.38253119 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.36966223 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.36071764 |
| 13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.31553269 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 2.28752730 |
| 15 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.26803126 |
| 16 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.09279339 |
| 17 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.06515482 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.04951376 |
| 19 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.03920584 |
| 20 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.98837208 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.97308580 |
| 22 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.95856995 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.91899493 |
| 24 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.89207955 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.88666912 |
| 26 | RNA polymerase_Homo sapiens_hsa03020 | 1.87773874 |
| 27 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.81798871 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.75479627 |
| 29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.68978355 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68724223 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.67141912 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.64950402 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.64020491 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.63521720 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.63411653 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.57748100 |
| 37 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.57719971 |
| 38 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.57657834 |
| 39 | Spliceosome_Homo sapiens_hsa03040 | 1.56994875 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.55822855 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52120583 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.51383341 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.45055667 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43816218 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.43596676 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.42459674 |
| 47 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.42262755 |
| 48 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.41157634 |
| 49 | Measles_Homo sapiens_hsa05162 | 1.38760784 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.35595170 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.35493804 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31123447 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30912621 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.30811807 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30003150 |
| 56 | Purine metabolism_Homo sapiens_hsa00230 | 1.28167355 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 1.24909011 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.20402022 |
| 59 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17453701 |
| 60 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.16815270 |
| 61 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.15354681 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 1.14250612 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.13087386 |
| 64 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.12661426 |
| 65 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.12468970 |
| 66 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10192884 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 1.09785777 |
| 68 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.09762126 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08481576 |
| 70 | Salivary secretion_Homo sapiens_hsa04970 | 1.07094093 |
| 71 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05818973 |
| 72 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.05777744 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 1.04410189 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03510773 |
| 75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.01831326 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 1.00410512 |
| 77 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99899439 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.98603943 |
| 79 | Pertussis_Homo sapiens_hsa05133 | 0.98452778 |
| 80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.97725672 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97118753 |
| 82 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.94939804 |
| 83 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94150474 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.91352602 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90935273 |
| 86 | Insulin secretion_Homo sapiens_hsa04911 | 0.90242130 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.89952170 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.88587823 |
| 89 | Shigellosis_Homo sapiens_hsa05131 | 0.88049100 |
| 90 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.88040938 |
| 91 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87419026 |
| 92 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.86618035 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86025079 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85502099 |
| 95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.84417452 |
| 96 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82899564 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.82700043 |
| 98 | Tuberculosis_Homo sapiens_hsa05152 | 0.82286805 |
| 99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80978942 |
| 100 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80956817 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.80891913 |
| 102 | Asthma_Homo sapiens_hsa05310 | 0.80889368 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79586627 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77975751 |
| 105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.77736897 |
| 106 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75535192 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73905361 |
| 108 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72815432 |
| 109 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72662535 |
| 110 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.72086467 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.71848792 |
| 112 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71512003 |
| 113 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.70848411 |
| 114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70726331 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70304373 |
| 116 | Influenza A_Homo sapiens_hsa05164 | 0.69969420 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.69941655 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68922856 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.68406545 |
| 120 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67972667 |
| 121 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.67321845 |
| 122 | Renin secretion_Homo sapiens_hsa04924 | 0.67011425 |
| 123 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.66351829 |
| 124 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64663618 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.63283664 |
| 126 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62712952 |
| 127 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62697500 |
| 128 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.62570112 |
| 129 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62567347 |
| 130 | Salmonella infection_Homo sapiens_hsa05132 | 0.61674010 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.60163683 |
| 132 | Platelet activation_Homo sapiens_hsa04611 | 0.59600535 |
| 133 | Huntingtons disease_Homo sapiens_hsa05016 | 0.59503145 |
| 134 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59355366 |
| 135 | GABAergic synapse_Homo sapiens_hsa04727 | 0.58952698 |
| 136 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58709529 |
| 137 | Malaria_Homo sapiens_hsa05144 | 0.58283658 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.58169829 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57778360 |
| 140 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57193513 |
| 141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55890652 |
| 142 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55740088 |
| 143 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.54836568 |
| 144 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53624558 |
| 145 | Hepatitis B_Homo sapiens_hsa05161 | 0.53554840 |
| 146 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53269644 |
| 147 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52035996 |
| 148 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.51778332 |
| 149 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51638199 |
| 150 | Cell cycle_Homo sapiens_hsa04110 | 0.50545030 |
| 151 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46698016 |
| 152 | Basal transcription factors_Homo sapiens_hsa03022 | 0.43959473 |
| 153 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.43449192 |
| 154 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43079379 |
| 155 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43064355 |
| 156 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42579246 |
| 157 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41987164 |
| 158 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.41705821 |
| 159 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.41580181 |
| 160 | Lysosome_Homo sapiens_hsa04142 | 0.41394852 |
| 161 | Apoptosis_Homo sapiens_hsa04210 | 0.41208531 |
| 162 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.41116096 |
| 163 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.40551220 |
| 164 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.40439233 |
| 165 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39340219 |
| 166 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38419265 |
| 167 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37858178 |
| 168 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37846370 |
| 169 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.36864957 |
| 170 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.36036757 |
| 171 | RNA transport_Homo sapiens_hsa03013 | 0.35650113 |
| 172 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.33236441 |
| 173 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.33167966 |
| 174 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.28355486 |
| 175 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.26985063 |
| 176 | Nicotine addiction_Homo sapiens_hsa05033 | 0.24587431 |
| 177 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22605399 |
| 178 | Alcoholism_Homo sapiens_hsa05034 | 0.20865550 |
| 179 | Long-term potentiation_Homo sapiens_hsa04720 | 0.20330952 |
| 180 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.19899592 |
| 181 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.18398841 |
| 182 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.17908877 |
| 183 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.16775892 |

